IL9 and B-cell chronic lymphocytic leukemia: By treating MEC1, a cell line derived from a CLL patient [94], with a STAT6 specific inhibitor, Chen and colleagues demonstrated that STAT6 is implicated in the regulation of IL-9 expression [95].